Effects of Serum Annexin Ⅱ, FIB and TM Changes on the Severity and Prognosis of Coronary Artery Disease in Patients with Coronary Heart Disease

YANG Lixia, DONG Li, GUO Haixia

PDF(985 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(985 KB)
Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (3) : 418-421. DOI: 10.11748/bjmy.issn.1006-1703.2022.03.013
Clinical Investigation

Effects of Serum Annexin Ⅱ, FIB and TM Changes on the Severity and Prognosis of Coronary Artery Disease in Patients with Coronary Heart Disease

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(3): 418-421 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.03.013

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(985 KB)

Accesses

Citation

Detail

Sections
Recommended

/